Liminatus Pharma, Inc. - 8-K Filing
Liminatus Pharma enters subscription agreement with non-U.S. investor for $650,002.50 private placement of common stock. (Items: 1.01 Entry into a Material Definitive Agreement, 3.02 Unregistered Sales of Equity Securities, 9.01 Financial Statements and Exhibits)
Tickers: $LIMN
Read the full article at SEC EDGAR
Part of the story RANGE IMPACT, INC. - 8-K Filing (14 articles)